Boyd Gilman

Boyd Gilman has more than 15 years of experience leading program evaluations and policy studies in health economics and financing for federal and state governments. His work focuses on Medicare hospital and post-acute care payment policy reform, Medicare outpatient prescription drug coverage, and cost of care for individuals with chronic conditions and other special health care needs, including those living with HIV/AIDS.

Gilman’s experience includes evaluations of the Medicare critical access hospital program and the Medicare rural community hospital demonstration to ensure that beneficiaries living in the least populated regions of the country have continued access to acute and emergency health care services. He has also used commercial, Medicaid, and Medicare claims to analyze the impact of drug benefit design on the use and cost of prescription medications, including a study to assess the cost-effectiveness of influenza vaccinations among the elderly.

In addition, Gilman has conducted numerous studies on access to and cost of health care services for people living with potentially disabling chronic conditions. For example, he helped develop a national needs-based system for allocating Ryan White CARE Act funds to state and local jurisdictions. He also recently evaluated the workforce needs of health care providers who treat a disproportionately large share of people living with HIV/AIDS. Gilman has also evaluated the savings associated with reducing adverse drug events in ambulatory care settings and the cost of implementing computerized physician order entry and clinical decision support systems in long-term care facilities.

Gilman publishes regularly in peer-reviewed journals such as Health Services Research, Medical Care, Health Care Financing Review, Journal of Rural Health, American Journal of Preventive Medicine, AIDS Care, and American Journal of Managed Care and presents at professional conferences for AcademyHealth, the American Public Health Association, the International AIDS Conference, and other groups. Before joining Mathematica in 2006, he was a senior economist at RTI International and Health Economics Research, Inc. He has a Ph.D. in economics from Boston University.